Tom Brassington

Tom Brassington


Email [email protected]​

Phone +44 20 7296 5589

Fax +44 20 7296 2001


Practice groupCorporate & Finance

'commercial in his attitude, view and outlook.'

Chambers UK

Tom Brassington is a leading partner in the firm's London Corporate & Finance practice group. He combines commercial acumen with transaction efficiency to ensure the best possible outcome for his clients.

He is ranked in Chambers Global for Corporate/M&A, with his experience in international and cross-border M&A highlighted in particular. He was also recently considered a "Corporate Rising Star" in the London market by Legal Business magazine.

He has experience across a wide variety of work including public and private M&A, joint ventures, restructurings, private equity, and equity capital markets. While Tom is a generalist M&A practitioner, he regularly acts for clients in the Life Sciences and Technology, Media & Telecoms sectors.

Much of Tom's work has a cross-border or international focus. While Tom is based in London, he has also practiced in both Dubai and Hong Kong.

Awards and recognitions


Acritas Star
Acritas Stars Independently Rated Lawyers


Corporate/M&A: (International & Cross-Border) - UK
Chambers Global

Education and admissions


The University of Nottingham


Member, City of London Solicitors' Company Law Committee

Law Society

Representative experience

Advising PerkinElmer, Inc. on public takeover offers for each Horizon Discovery Group plc and Oxford Immunotec Global Plc

Advising Smiths Group plc on the acquisitions of Seebach GmbH and United Flexible, Inc.

Advising The Anschutz Corporation in respect of the US$5.8bn acquisition of Regal Entertainment Group by Cineworld Group plc.

Advising Recordati on its US$300m acquisition of the European commercial rights to AstraZeneca's blood pressure and heart failure products, Seloken, Seloken ZOK and Logimax.

Advising McCormick & Co. on its takeover offer for Premier Foods plc.

Advising News Corporation on various transactions including the acquisitions of Shine and Unruly.

Advising Lockheed Martin on various transactions, including the separation and combination of its IT and technical services businesses with Leidos.

Advising Intrexon Corporation on the acquisition of Oxitec Ltd., a pioneer in biological insect control solutions.

Advising Google on a variety of corporate transactions in the UK.

Advising Jazz Pharmaceuticals PLC on the sale of a portfolio of pharmaceutical products and medical devices to Essex Woodlands Fund IX L.P.

Advising Kingfisher PLC on the sale of its controlling stake in B&Q China to Beijing-based Wumei Holdings.

Advising Johnson and Johnson on transactions including acquisitions of Spectrum Vision; OTC brands of JB Chemicals & Pharmaceuticals Limited; and Finsbury Orthopaedics on business disposal.

Advising Bestway Group on the acquisition of the Co-operative Group's Pharmacy business for £620m.


Advising Aeroflex on its US$1.5bn sale to Cobham plc.

Advising the trustees of the Kodak Pension Plan on the acquisition of the Personalized Imaging and Document Imaging businesses of Eastman Kodak.

Advising Ares Capital on its participation in a debt-for-equity swap and placing, and then subsequent take private, of Healthcare Locums plc.

Advising RBC Capital Markets as sponsor to Petra Diamonds Limited's admission to the Official List and to trading on the Main Market of the LSE.

Advising Moor Park on the £700m sale and leaseback of 12 Spire Healthcare hospitals.

Advising Numis Securities Limited in its capacity as nominated adviser and broker to Clinigen Group Plc on Clinigen's IPO and admission to AIM.

Loading data